370 filings
6-K
BNTX
BioNTech SE
20 Sep 24
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
9:17am
6-K
BNTX
BioNTech SE
5 Sep 24
BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024
8:53am
6-K
BNTX
BioNTech SE
22 Aug 24
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
4:31pm
6-K
BNTX
BioNTech SE
19 Aug 24
Current report (foreign)
8:34am
6-K
BNTX
BioNTech SE
16 Aug 24
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
6:56am
6-K
8qz19ol2
6 Aug 24
Current report (foreign)
7:20pm
6-K
mihxr0z9yozo1f
5 Aug 24
Current report (foreign)
6:34am
6-K
ym3a54pgban24saqf
5 Aug 24
BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
6:32am
6-K
y0bukpn4w ax
30 Jul 24
Current report (foreign)
9:08am
6-K
df5du0l
27 Jun 24
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
5:37pm
6-K
vwls13fr8
24 Jun 24
Current report (foreign)
8:07am
6-K
by8nmoqk1 ulv9va0
17 Jun 24
Current report (foreign)
7:18am
6-K
vlcmlqifc
3 Jun 24
Current report (foreign)
7:46am
6-K
felnk3whv9dp3s
29 May 24
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
7:21pm
6-K
cn1xpzu zs1
21 May 24
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
4:36pm
6-K
2sa2td0x
17 May 24
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
4:10pm
6-K
n7os4cbxu
6 May 24
Current report (foreign)
7:18am
6-K
krhyhh9
6 May 24
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
6:48am
6-K
a35azbdw 2dt58
8 Apr 24
Invitation to the Annual General Meeting 2024
5:05pm
6-K
4qv9pu8omgs vav1hydf
8 Apr 24
Current report (foreign)
7:12am